Shares of Neuphoria Therapeutics Inc. soared more than 11% in premarket trading on Wednesday, propelling the micro-cap ...
UL Solutions Inc. , a global safety science leader, today announced that its board of directors has declared a quarterly dividend of $0.13 per share, an increase of $0.005 per share, bringing the ...
The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.
Non-U.S. developed markets stocks finished the fourth quarter lower. Political uncertainty in some of the largest European ...
JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...
The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...
Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...
BEIJING, Feb 14 (Reuters) - China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, corn, and soybean varieties, as part of ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...
Feb. 12, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN ... We specifically targeted the moderate stage population as they represent about 30% of all Alzheimer’s cases and most, if not all ...
Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with $52.0 million in upfront payments Extended ant ...
Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...